Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection (original) (raw)

• Hotchkiss, R.S. & Karl, I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138–150 (2003).
  Article CAS Google Scholar
• Riedemann, N.C., Guo, R.F. & Ward, P.A. Novel strategies for the treatment of sepsis. Nat. Med. 9, 517–524 (2003).
  Article CAS Google Scholar
• Olson, T.S. & Ley, K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R7–R28 (2002).
  Article CAS Google Scholar
• Alves-Filho, J.C. et al. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. USA 106, 4018–4023 (2009).
  Article CAS Google Scholar
• Vroon, A., Heijnen, C.J. & Kavelaars, A. GRKs and arrestins: regulators of migration and inflammation. J. Leukoc. Biol. 80, 1214–1221 (2006).
  Article CAS Google Scholar
• Penela, P., Ribas, C. & Mayor, F. Jr. Mechanisms of regulation of the expression and function of G protein–coupled receptor kinases. Cell. Signal. 15, 973–981 (2003).
  Article CAS Google Scholar
• Schmitz, J. et al. IL-33, an interleukin-1–like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2–associated cytokines. Immunity 23, 479–490 (2005).
  Article CAS Google Scholar
• Chackerian, A.A. et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551–2555 (2007).
  Article CAS Google Scholar
• Ali, S. et al. IL-1 receptor accessory protein is essential for IL-33–induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104, 18660–18665 (2007).
  Article CAS Google Scholar
• Xu, D. et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187, 787–794 (1998).
  Article CAS Google Scholar
• Moritz, D.R., Rodewald, H.R., Gheyselinck, J. & Klemenz, R. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 161, 4866–4874 (1998).
  CAS PubMed Google Scholar
• Coyle, A.J. et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2–mediated lung mucosal immune responses. J. Exp. Med. 190, 895–902 (1999).
  Article CAS Google Scholar
• Löhning, M. et al. T1/ST2 is preferentially expressed on murine TH2 cells, independent of interleukin 4, interleukin 5 and interleukin 10, and important for TH2 effector function. Proc. Natl. Acad. Sci. USA 95, 6930–6935 (1998).
  Article Google Scholar
• Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of Toll-like receptor–mediated immune responses. Nat. Rev. Immunol. 5, 446–458 (2005).
  Article CAS Google Scholar
• Brint, E.K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5, 373–379 (2004).
  Article CAS Google Scholar
• Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).
  Article CAS Google Scholar
• Plitas, G., Burt, B.M., Nguyen, H.M., Bamboat, Z.M. & DeMatteo, R.P. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205, 1277–1283 (2008).
  Article CAS Google Scholar
• Alves-Filho, J.C., de Freitas, A., Russo, M. & Cunha, F.Q. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34, 461–470 (2006).
  Article CAS Google Scholar
• Roger, T. et al. Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 106, 2348–2352 (2009).
  Article CAS Google Scholar
• Spiller, S. et al. TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice. J. Exp. Med. 205, 1747–1754 (2008).
  Article CAS Google Scholar
• Angus, D.C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit. Care Med. 29, 1303–1310 (2001).
  Article CAS Google Scholar
• Hubbard, W.J. et al. Cecal ligation and puncture. Shock 24 Suppl 1, 52–57 (2005).
  Article Google Scholar
• Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173–182 (2006).
  Article CAS Google Scholar
• Cavaillon, J.M., Adib-Conquy, M., Fitting, C., Adrie, C. & Payen, D. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 35, 535–544 (2003).
  Article CAS Google Scholar
• Brown, K.A. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157–169 (2006).
  Article CAS Google Scholar
• Cummings, C.J. et al. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162, 2341–2346 (1999).
  CAS PubMed Google Scholar
• Rios-Santos, F. et al. Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase–derived nitric oxide. Am. J. Respir. Crit. Care Med. 175, 490–497 (2007).
  Article CAS Google Scholar
• Suzukawa, M. et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181, 5981–5989 (2008).
  Article CAS Google Scholar
• Mueller, S.G., White, J.R., Schraw, W.P., Lam, V. & Richmond, A. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J. Biol. Chem. 272, 8207–8214 (1997).
  Article CAS Google Scholar
• Kurowska-Stolarska, M. et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183, 6469–6477 (2009).
  Article CAS Google Scholar
• Arraes, S.M. et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 108, 2906–2913 (2006).
  Article CAS Google Scholar
• Loniewski, K., Shi, Y., Pestka, J. & Parameswaran, N. Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. Mol. Immunol. 45, 2312–2322 (2008).
  Article CAS Google Scholar
• Cherry, W.B., Yoon, J., Bartemes, K.R., Iijima, K. & Kita, H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121, 1484–1490 (2008).
  Article CAS Google Scholar
• Xu, D. et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 105, 10913–10918 (2008).
  Article CAS Google Scholar
• Pushparaj, P.N. et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl. Acad. Sci. USA 106, 9773–9778 (2009).
  Article CAS Google Scholar
• Komai-Koma, M. et al. IL-33 is a chemoattractant for human TH2 cells. Eur. J. Immunol. 37, 2779–2786 (2007).
  Article CAS Google Scholar
• Townsend, M.J., Fallon, P.G., Matthews, D.J., Jolin, H.E. & McKenzie, A.N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191, 1069–1076 (2000).
  Article CAS Google Scholar
• Manley, M.O., O'Riordan, M.A., Levine, A.D. & Latifi, S.Q. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23, 521–526 (2005).
  CAS PubMed Google Scholar
• Levy, M.M. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250–1256 (2003).
  Article Google Scholar